Structural and mechanistic studies on the inhibition of the hypoxia-inducible transcription factor hydroxylases by tricarboxylic acid cycle intermediates.
In humans both the levels and activity of the alpha-subunit of the hypoxia-inducible transcription factor (HIF-alpha) are regulated by its post-translation hydroxylation as catalyzed by iron- and 2-oxoglutarate (2OG)-dependent prolyl and asparaginyl hydroxylases (PHD1-3 and factor-inhibiting HIF (FI...
Main Authors: | , , , , , , , , |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2007
|
_version_ | 1826258285691404288 |
---|---|
author | Hewitson, K Liénard, B McDonough, M Clifton, I Butler, D Soares, A Oldham, N McNeill, L Schofield, C |
author_facet | Hewitson, K Liénard, B McDonough, M Clifton, I Butler, D Soares, A Oldham, N McNeill, L Schofield, C |
author_sort | Hewitson, K |
collection | OXFORD |
description | In humans both the levels and activity of the alpha-subunit of the hypoxia-inducible transcription factor (HIF-alpha) are regulated by its post-translation hydroxylation as catalyzed by iron- and 2-oxoglutarate (2OG)-dependent prolyl and asparaginyl hydroxylases (PHD1-3 and factor-inhibiting HIF (FIH), respectively). One consequence of hypoxia is the accumulation of tricarboxylic acid cycle intermediates (TCAIs). In vitro assays were used to assess non-2OG TCAIs as inhibitors of purified PHD2 and FIH. Under the assay conditions, no significant FIH inhibition was observed by the TCAIs or pyruvate, but fumarate, succinate, and isocitrate inhibited PHD2. Mass spectrometric analyses under nondenaturing conditions were used to investigate the binding of TCAIs to PHD2 and supported the solution studies. X-ray crystal structures of FIH in complex with Fe(II) and fumarate or succinate revealed similar binding modes for each in the 2OG co-substrate binding site. The in vitro results suggest that the cellular inhibition of PHD2, but probably not FIH, by fumarate and succinate may play a role in the Warburg effect providing that appropriate relative concentrations of the components are achieved under physiological conditions. |
first_indexed | 2024-03-06T18:31:34Z |
format | Journal article |
id | oxford-uuid:09d28232-edab-450f-a5ba-785662b0a990 |
institution | University of Oxford |
language | English |
last_indexed | 2024-03-06T18:31:34Z |
publishDate | 2007 |
record_format | dspace |
spelling | oxford-uuid:09d28232-edab-450f-a5ba-785662b0a9902022-03-26T09:20:27ZStructural and mechanistic studies on the inhibition of the hypoxia-inducible transcription factor hydroxylases by tricarboxylic acid cycle intermediates.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:09d28232-edab-450f-a5ba-785662b0a990EnglishSymplectic Elements at Oxford2007Hewitson, KLiénard, BMcDonough, MClifton, IButler, DSoares, AOldham, NMcNeill, LSchofield, CIn humans both the levels and activity of the alpha-subunit of the hypoxia-inducible transcription factor (HIF-alpha) are regulated by its post-translation hydroxylation as catalyzed by iron- and 2-oxoglutarate (2OG)-dependent prolyl and asparaginyl hydroxylases (PHD1-3 and factor-inhibiting HIF (FIH), respectively). One consequence of hypoxia is the accumulation of tricarboxylic acid cycle intermediates (TCAIs). In vitro assays were used to assess non-2OG TCAIs as inhibitors of purified PHD2 and FIH. Under the assay conditions, no significant FIH inhibition was observed by the TCAIs or pyruvate, but fumarate, succinate, and isocitrate inhibited PHD2. Mass spectrometric analyses under nondenaturing conditions were used to investigate the binding of TCAIs to PHD2 and supported the solution studies. X-ray crystal structures of FIH in complex with Fe(II) and fumarate or succinate revealed similar binding modes for each in the 2OG co-substrate binding site. The in vitro results suggest that the cellular inhibition of PHD2, but probably not FIH, by fumarate and succinate may play a role in the Warburg effect providing that appropriate relative concentrations of the components are achieved under physiological conditions. |
spellingShingle | Hewitson, K Liénard, B McDonough, M Clifton, I Butler, D Soares, A Oldham, N McNeill, L Schofield, C Structural and mechanistic studies on the inhibition of the hypoxia-inducible transcription factor hydroxylases by tricarboxylic acid cycle intermediates. |
title | Structural and mechanistic studies on the inhibition of the hypoxia-inducible transcription factor hydroxylases by tricarboxylic acid cycle intermediates. |
title_full | Structural and mechanistic studies on the inhibition of the hypoxia-inducible transcription factor hydroxylases by tricarboxylic acid cycle intermediates. |
title_fullStr | Structural and mechanistic studies on the inhibition of the hypoxia-inducible transcription factor hydroxylases by tricarboxylic acid cycle intermediates. |
title_full_unstemmed | Structural and mechanistic studies on the inhibition of the hypoxia-inducible transcription factor hydroxylases by tricarboxylic acid cycle intermediates. |
title_short | Structural and mechanistic studies on the inhibition of the hypoxia-inducible transcription factor hydroxylases by tricarboxylic acid cycle intermediates. |
title_sort | structural and mechanistic studies on the inhibition of the hypoxia inducible transcription factor hydroxylases by tricarboxylic acid cycle intermediates |
work_keys_str_mv | AT hewitsonk structuralandmechanisticstudiesontheinhibitionofthehypoxiainducibletranscriptionfactorhydroxylasesbytricarboxylicacidcycleintermediates AT lienardb structuralandmechanisticstudiesontheinhibitionofthehypoxiainducibletranscriptionfactorhydroxylasesbytricarboxylicacidcycleintermediates AT mcdonoughm structuralandmechanisticstudiesontheinhibitionofthehypoxiainducibletranscriptionfactorhydroxylasesbytricarboxylicacidcycleintermediates AT cliftoni structuralandmechanisticstudiesontheinhibitionofthehypoxiainducibletranscriptionfactorhydroxylasesbytricarboxylicacidcycleintermediates AT butlerd structuralandmechanisticstudiesontheinhibitionofthehypoxiainducibletranscriptionfactorhydroxylasesbytricarboxylicacidcycleintermediates AT soaresa structuralandmechanisticstudiesontheinhibitionofthehypoxiainducibletranscriptionfactorhydroxylasesbytricarboxylicacidcycleintermediates AT oldhamn structuralandmechanisticstudiesontheinhibitionofthehypoxiainducibletranscriptionfactorhydroxylasesbytricarboxylicacidcycleintermediates AT mcneilll structuralandmechanisticstudiesontheinhibitionofthehypoxiainducibletranscriptionfactorhydroxylasesbytricarboxylicacidcycleintermediates AT schofieldc structuralandmechanisticstudiesontheinhibitionofthehypoxiainducibletranscriptionfactorhydroxylasesbytricarboxylicacidcycleintermediates |